205 related articles for article (PubMed ID: 9108411)
21. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
22. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
Kamps MP; Baltimore D
Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.
Troussard X; Rimokh R; Valensi F; Leboeuf D; Fenneteau O; Guitard AM; Manel AM; Schillinger F; Leglise C; Brizard A
Br J Haematol; 1995 Mar; 89(3):516-26. PubMed ID: 7734349
[TBL] [Abstract][Full Text] [Related]
24. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
Van Dijk MA; Voorhoeve PM; Murre C
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
[TBL] [Abstract][Full Text] [Related]
25. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
Maloney KW; McGavran L; Odom LF; Hunger SP
Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
[TBL] [Abstract][Full Text] [Related]
26. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
27. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia.
Shearer BM; Flynn HC; Knudson RA; Ketterling RP
Br J Haematol; 2005 Apr; 129(1):45-52. PubMed ID: 15801954
[TBL] [Abstract][Full Text] [Related]
28. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML
Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665
[TBL] [Abstract][Full Text] [Related]
29. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
30. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
31. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
32. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.
Behm FG; Smith FO; Raimondi SC; Pui CH; Bernstein ID
Blood; 1996 Feb; 87(3):1134-9. PubMed ID: 8562939
[TBL] [Abstract][Full Text] [Related]
33. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
[TBL] [Abstract][Full Text] [Related]
34. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13).
Yuki Y; Imoto I; Imaizumi M; Hibi S; Kaneko Y; Amagasa T; Inazawa J
Cancer Sci; 2004 Jun; 95(6):503-7. PubMed ID: 15182431
[TBL] [Abstract][Full Text] [Related]
37. [Variant fusion transcript in ALL children with E2A-PBX1 fusion gene positive].
Li ZG; Zhao W; Wu MY; Hu YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):516-20. PubMed ID: 16800933
[TBL] [Abstract][Full Text] [Related]
38. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation.
Kamps MP
Curr Top Microbiol Immunol; 1997; 220():25-43. PubMed ID: 9103673
[No Abstract] [Full Text] [Related]
39. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
Chang CP; de Vivo I; Cleary ML
Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
[TBL] [Abstract][Full Text] [Related]
40. Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia.
Izraeli S; Kovar H; Gadner H; Lion T
Blood; 1992 Sep; 80(6):1413-7. PubMed ID: 1520867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
